Clinical Trials
8
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Galmed Research and Development, Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT06095986
- Locations
- 🇺🇸
The Sanyal Institute for Liver Disease & Metabolic Health at VCU, Richmond, Virginia, United States
Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment
- Conditions
- Hepatic Impairment
- Interventions
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Galmed Research and Development, Ltd.
- Target Recruit Count
- 57
- Registration Number
- NCT04480827
- Locations
- 🇺🇸
Division of Clinical Pharmacology, University of Miami, Miami, Florida, United States
🇺🇸Orlando Clinical Research Center, Orlando, Florida, United States
🇺🇸Alliance for Multispecialty Research, Knoxville, Tennessee, United States
A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)
- Conditions
- Nonalcoholic Steatohepatitis (NASH)
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Galmed Research and Development, Ltd.
- Target Recruit Count
- 157
- Registration Number
- NCT04104321
- Locations
- 🇺🇸
The Public Health Trust of Miami-Dade County, Florida, dba the Jackson Health System, Miami, Florida, United States
🇺🇸Texas Clinical Research Institute, LLC, Arlington, Texas, United States
A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH
- Conditions
- Non-Alcoholic SteatohepatitisFatty LiverLiver DiseasesLiver Fibroses
- Interventions
- First Posted Date
- 2014-10-31
- Last Posted Date
- 2021-07-14
- Lead Sponsor
- Galmed Research and Development, Ltd.
- Target Recruit Count
- 247
- Registration Number
- NCT02279524
- Locations
- 🇺🇸
Profil Institue for Clinical Research Inc., Chula Vista, California, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸California Liver Research Institute, Pasadena, California, United States